Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Bate

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Drug Safety|August 28, 2019
Transparent Reporting on Research Using Unstructured Electronic Health Record Data to Generate 'Real World' Evidence of Comparative Effectiveness and SafetyShirley V Wang, Olga V Patterson, Joshua J Gagne, et al.
Pharmacoepidemiology and Drug Safety|October 24, 2019
The International Society for Pharmacoepidemiology's Comments on the Core Recommendations in the Summary of the Heads of Medicines Agencies (HMA) - EMA Joint Big Data Task ForceAnton Pottegård, Olaf Klungel, Almut Winterstein, et al.
Drug Safety|February 24, 2023
Correction to: Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping ReviewBenjamin Kompa, Joe B Hakim, Anil Palepu, et al.
Drug Safety|May 17, 2022
Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping ReviewBenjamin Kompa, Joe B Hakim, Anil Palepu, et al.
Drug Safety|June 10, 2015
A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety SurveillanceYihua Xu, Xiaofeng Zhou, Brandon T Suehs, et al.
Drug Safety|July 3, 2015
Erratum to: A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety SurveillanceYihua Xu, Xiaofeng Zhou, Brandon T Suehs, et al.
Pharmacoepidemiology and Drug Safety|April 17, 2024
Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industryVicki Osborne, Amie Goodin, Joshua Brown, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2016
Risk of acute liver injury associated with use of antibiotics. Comparative cohort and nested case-control studies using two primary care databases in EuropeRuth Brauer, Ian Douglas, Luis Alberto Garcia Rodriguez, et al.
Pharmacoepidemiology and Drug Safety|October 9, 2025
Recommendations to Enable Broader Use of Real-World Evidence to Inform Decision-Making Throughout Pharmacovigilance Signal ManagementG Niklas Norén, Katherine Donegan, Monica A Muñoz, et al.
Drug Safety|March 9, 2016
Good Signal Detection Practices: Evidence from IMI PROTECTAntoni F Z Wisniewski, Andrew Bate, Cedric Bousquet, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Drug Safety|August 28, 2019
Transparent Reporting on Research Using Unstructured Electronic Health Record Data to Generate 'Real World' Evidence of Comparative Effectiveness and SafetyShirley V Wang, Olga V Patterson, Joshua J Gagne, et al.
Pharmacoepidemiology and Drug Safety|October 24, 2019
The International Society for Pharmacoepidemiology's Comments on the Core Recommendations in the Summary of the Heads of Medicines Agencies (HMA) - EMA Joint Big Data Task ForceAnton Pottegård, Olaf Klungel, Almut Winterstein, et al.
Drug Safety|February 24, 2023
Correction to: Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping ReviewBenjamin Kompa, Joe B Hakim, Anil Palepu, et al.
Drug Safety|May 17, 2022
Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping ReviewBenjamin Kompa, Joe B Hakim, Anil Palepu, et al.
Drug Safety|June 10, 2015
A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety SurveillanceYihua Xu, Xiaofeng Zhou, Brandon T Suehs, et al.
Drug Safety|July 3, 2015
Erratum to: A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety SurveillanceYihua Xu, Xiaofeng Zhou, Brandon T Suehs, et al.
Pharmacoepidemiology and Drug Safety|April 17, 2024
Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industryVicki Osborne, Amie Goodin, Joshua Brown, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2016
Risk of acute liver injury associated with use of antibiotics. Comparative cohort and nested case-control studies using two primary care databases in EuropeRuth Brauer, Ian Douglas, Luis Alberto Garcia Rodriguez, et al.
Pharmacoepidemiology and Drug Safety|October 9, 2025
Recommendations to Enable Broader Use of Real-World Evidence to Inform Decision-Making Throughout Pharmacovigilance Signal ManagementG Niklas Norén, Katherine Donegan, Monica A Muñoz, et al.
Drug Safety|March 9, 2016
Good Signal Detection Practices: Evidence from IMI PROTECTAntoni F Z Wisniewski, Andrew Bate, Cedric Bousquet, et al.
Pageof 11